Uncategorized -

Knight Supports Crescita Trajectory

MONTREAL, QUEBEC–(Marketwired – Aug. 14, 2017) – Knight Therapeutics Inc. (TSX:GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, announced today [...]

Read More